Kari M. Morrissey

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Kyung Hae Jung, Patricia LoRusso, Howard A. Burris et al. · Clinical Cancer Research · 2019 · 286 citations · Full text

Medicine, Oncology, Pharmacology +17

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Ligong Chen, Yan Shu, Xiaomin Liang et al. · Proceedings of the National Academy of Sciences · 2014 · 237 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin

Sophie L. Stocker, Kari M. Morrissey, Sook Wah Yee et al. · Clinical Pharmacology & Therapeutics · 2012 · 190 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

The UCSF-FDA TransPortal: A Public Drug Transporter Database

Kari M. Morrissey, C C Wen, Susan J. Johns et al. · Clinical Pharmacology & Therapeutics · 2012 · 166 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin

J.H. Choi, Sook Wah Yee, Andrea H. Ramirez et al. · Clinical Pharmacology & Therapeutics · 2011 · 155 citations

Veterinary Medicine, Genetics, Pharmacology +17